Conversation with Raphael Mechoulam

Addiction

Volumn 102, Issue 6, 2007, Pages 887-893

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABIS; LIGAND;

ADDICTION; BINDING AFFINITY; BIOLOGICAL ACTIVITY; DRUG ISOLATION; HUMAN; ISRAEL; MEDICAL RESEARCH; NEUROPHYSIOLOGY; NEUROPROTECTION; NOMENCLATURE; NOTE; SCIENTIST;

CANNABINOIDS; CANNABIS; LIGANDS; RESEARCH; TETRAHYDROCANNABINOL;

EID: 34249086505     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.01795.x     Document Type: Note

References (18)

1. Mechoulam R., Shvo Y. The structure of cannabidiol. Tetrahedron 1963 19 : 2073 8.
2. Malfait A. M., Gallily R., Sumariwalla P. F., Malik A. S., Andreakos E., Mechoulam R. et al. The non-psychoactive cannabis-constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci USA 2000 97 : 9561 6.
3. Cunha J. M., Carlini E. A., Pereira A. E., Ramos O. L., Pimentel G., Gagliardi R. et al. Chronic administration of CBD to healthy volunteers and epileptic patients. Pharmacologia 1980 21 : 175 85.
4. Murillo-Rodriguez E., Millan-Aldaco D., Palomero-Rivero M., Prospero-Garcia O., Mechoulam R., Drucker-Colin R. Cannabidiol, a constituent of Cannabis sativa, modulates sleep in rats. FEBS Lett 2006 580 : 4337 45.
5. Carrier E. J., Auchampach J. A., Hillard C. J. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc Natl Acad Sci USA 2006 103 : 7895 900.
6. Weiss L., Zeira M., Reich S., Har-Noy M., Mechoulam R., Slavin S. et al. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity 2006 39 : 143 51.
7. Gaoni Y., Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964 86 : 1646 7.
8. Thomas A., Stevenson L. A., Wease K. N., Pryce M. R., Baillie G., Ross R. A. et al. Evidence that the plant cannabinoid delta-9-cannabivarin is a cannabinoid CB1 and CB2 receptor agonist. Br J Pharmacol 2005 146 : 917 26.
9. Mechoulam R., Braun P., Gaoni Y. Syntheses of Δ1-THC and related cannabinoids. J Am Chem Soc 1972 94 : 6159 65.
10. Mechoulam R. Marihuana chemistry. Science 1970 168 : 1159 66.
11. Mechoulam R., Ben-Zvi Z., Agurell S., Nilsson I. M., Nilsson J. L. G., Edery H., et al. Δ6-Tetrahydrocannabinol-7-oic acid, a urinary Δ6-THC metabolite: isolation and synthesis. Experientia 1973 29 : 1193 5.
12. Devane D. C., Dysarz F. A., Johnson M. R., Melvin L. S., Howlett A. C. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988 34 : 605 13.
13. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G. et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992 258 : 1946 9.
14. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N. E., Schatz A. R. et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995 50 : 83 90.
15. Baker D., Pryce G., Davies W. L., Hiley C. R. In silico patent searching reveals a new cannabinoid receptor. Trends Pharmacol Sci 2006 27 : 1 4.
16. Milman G., Maor Y., Abu-Lafi S., Horowitz M., Gallily R., Batkai S. et al. N-Arachidonoyl 1-serine, a novel endocannabinoid-like brain constituent with vasodilatory properties. Proc Natl Acad Sci USA 2006 103 : 2428 33.
17. Panikashvili D., Simeonidou C., Ben-Shabat S., Hanus L., Breuer A., Mechoulam R. et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 2001 413 : 527 31.
18. Pachter P., Batkai S., Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006 58 : 389 462.